JAK2 and breast cancer: Can inhibit JAK2/STAT3 pathway activation; regulate upstream and downstream indicators; suppress BC cell growth, proliferation, and migration; promote cancer cell apoptosis; and reduce inflammatory responses, thereby exerting anti-BC effects.